Patents/Inventors

Ugur Sahin

MainzDE65 patents

56 Patents

US126114492026
Individualized Vaccines for Cancer
Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz Gemeinnützige GmbH
0 cites
US125996602026
Therapeutic RNA for Hpv-positive Cancer
Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz Ggmbh
0 cites
US125952922026
Interleukin-2 Receptor (IL2R) and Interleukin-2 (IL2) Variants for Specific Activation of Immune Effector Cells
BIONTECH CELL & GENE THERAPIES GmbH
0 cites
US125707512026
Binding Agents Binding to PD-L1 and CD137 and Use Thereof
BIONTECH SE
0 cites
US125595312026
Claudin-6-specific Immunoreceptors and T Cell Epitopes
ASTELLAS PHARMA Inc.
0 cites
US124601982025
Method for Reducing Immunogenicity of RNA
Biontech SE
0 cites
US124213192025
Binding Agents That Bind OX40 (CD134) and Method of Use Thereof to Treat Disease
GENMAB A/S
0 cites
US124102582025
Antibodies Capable of Binding to OX40, Variants Thereof and Uses Thereof
Biontech SE
0 cites
US124102212025
Tumor Antigens for Determining Cancer Therapy
Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz
0 cites
US123982142025
Binding Agents Binding to Epcam and CD137
Biontech SE
0 cites
US123850492025
Modification of RNA, Producing an Increased Transcript Stability and Translation Efficiency
Biontech SE
0 cites
US123785312025
Use of RNA for Reprogramming Somatic Cells
BIONTECH SE
0 cites
US123384482025
Trans-replicating RNA
BIONTECH SE
0 cites
US122917172025
RNA Replicon for Reprogramming Somatic Cells
Tron-translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz Gemeinnützige GmbH
0 cites
US122813222025
RNA Replicon for Versatile and Efficient Gene Expression
Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz Gemeinnützige GmbH
0 cites
US122811382025
5′-cap-trinucleotide- or Higher Oligonucleotide Compounds and Their Use in Stabilizing RNA, Expressing Proteins in Therapy
Biontech RNA Pharmaceuticals GmbH
0 cites
US122708132025
Methods for Predicting the Usefulness of Disease Specific Amino Acid Modifications for Immunotherapy
Biontech SE
0 cites
US122081362025
Coronavirus Vaccine
Biontech SE
0 cites
US121863872025
Coronavirus Vaccine
Biontech SE
0 cites
US121880972025
Methods and Compositions for Prediction of Therapeutic Efficacy of Cancer Treatments and Cancer Prognosis
Tron-translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz
0 cites
US121862752025
Enhancing the Effect of Car-engineered T Cells by Means of Nucleic Acid Vaccination
Biontach Ceil & Gene Therapies GmbH And Tron—translationaie Onkologie An Der Universitaismedizin Der Johannes Gutenberg-univer
0 cites
US121680512024
0 cites
US121530412024
Methods for Predicting the Usefulness of Proteins or Protein Fragments for Immunotherapy
Biontech SE
0 cites
US121509472024
Formulation for Administration of RNA
TRON—TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ
0 cites
US121338992024
Coronavirus Vaccine
Biontech SE
0 cites
US120775962024
Multispecific Antibodies Against CD40 and CD137
Biontech SE
0 cites
US120594642024
Combination Therapy Involving Antibodies Against Claudin 18.2 for Treatment of Cancer
Tron—translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-universitat Mainz
0 cites
US120547232024
Stabilization of Poly(a) Sequence Encoding DNA Sequences
Tron-translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz Ggmbh
0 cites
US119761302024
Antibodies Against Claudin 18.2 Useful in Cancer Diagnosis
Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes
0 cites
US119511852024
RNA Constructs and Uses Thereof
Biontech SE
0 cites
US119393882024
Multispecific Antibodies Against CD40 and CD137
Biontech SE
0 cites
US119326932024
Monoclonal Antibodies Directed Against Programmed Death-1 Protein and Their Use in Medicine
Genmab A/S
0 cites
US119256942024
Coronavirus Vaccine
Biontech SE
0 cites
US119201942024
Methods for Characterizing Loss of Antigen Presentation
Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz
0 cites
US119199512024
Antibodies Useful in Cancer Diagnosis
Tron-translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz
0 cites
US118780552024
Coronavirus Vaccine
Biontech SE
0 cites
US118734782024
Method for Reducing Immunogenicity of RNA
Biontech SE
0 cites
US118651592024
Therapeutic RNA
Sanofi
0 cites
US118590082024
Antibodies for Treatment of Cancer Expressing Claudin 6
Johannes Gutenberg-universität Mainz
0 cites
US118589882024
Antibodies Specific for Claudin 6 (CLDN6)
Johannes Gutenberg-universität Mainz
0 cites
US118264022023
Combination Therapy Involving Antibodies Against Claudin 18.2 for Treatment of Metastatic Pancreatic Adenocarcinoma
Tron-translationale Onkologie An Der Universitatsm
0 cites
US118144112023
Nucleic Acid Molecules Encoding Binding Agents to CD40 and 4-1BB (CD137)
GENMAB A/S
0 cites
US117952182023
Diagnosis and Therapy of Cancer Involving Cancer Stem Cells
Tron—translationale Onkologie An Der Universität
0 cites
US117878622023
Bispecific Trivalent Antibodies Binding to Claudin6 or Claudin18.2 and CD3 for Treatment of Claudin Expressing Cancer Diseases
ASTELLAS PHARMA Inc.
0 cites
US117796592023
RNA Constructs and Uses Thereof
Biontech SE
0 cites
US117391392023
Monoclonal Antibodies Against Claudin-18 for Treatment of Cancer
TRON—TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄT
0 cites
US117323082023
Methods and Compositions for Prediction of Therapeutic Efficacy of Cancer Treatments and Cancer Prognosis
TRON—TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GGMBH
0 cites
US117133462023
Claudin-18.2-specific Immunoreceptors and T Cell Epitopes
Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz Gemeinnützige GmbH
0 cites
US117026312023
Antigen Receptors and Uses Thereof
BIONTECH CELL & GENE THERAPIES GmbH
0 cites
US117014132023
RNA for Treatment of Autoimmune Diseases
Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz Gemeinnützige GmbH
0 cites
US116739392023
Compositions and Methods for Diagnosis and Treatment of Cancer
BIONTECH SE
0 cites
US116603382023
Particles Comprising a Shell with RNA
TRON
0 cites
US116282092023
Tumor Antigens for Determining Cancer Therapy
Biontech SE
0 cites
US115595872023
RNA Formulation for Immunotherapy
Biontech SE
0 cites
US115476732023
Coronavirus Vaccine
Biontech SE
0 cites
US115411272023
Drug Conjugates Comprising Antibodies Against Claudin 18.2
Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz Gemeinnützige GmbH
0 cites